1-4 of 4
Junia Melo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients.

Nicola Esposito, PhD, Concetta Quintarelli, PhD, Irene Colavita, PhD, Barbara Izzo, PhD, Anna Lucia Peluso, PhD, Margherita Ruoppolo, PhD, Luigi Del Vecchio, MD, Domenico Russo, Susan Branford, PhD, Ilaria Iacobucci, PhD, Mark Thornquist, Matt Barnett, Junia Melo, Giuseppe Saglio, Jerald Radich, Lin Peter, Giovanni Martinelli, Thea Kalebic, MD, Timothy Hughes, Fabrizio Pane
Journal: Blood
Blood (2009) 114 (22): 2212.
https://doi.org/10.1182/blood.V114.22.2212.2212
Published: 2009
Journal Articles

A decreased Level of Shp1 provides an additive survival advantage to the Ph+ Cells of CML Patients and may account for Resistance to Imatinib Treatment

Nicola Esposito, PhD, Irene Colavita, PhD, Fabrizio Quarantelli, PhD, Barbara Izzo, PhD, Luigia Luciano, MD, Luigi Del Vecchio, MD, Timothy Hughes, Jerald Radich, Domenico Russo, MD, Simona Soverini, PhD, Ilaria Iacobucci, PhD, Giovanni Martinelli, MD, Giuseppe Saglio, MD, Junia Melo, MD, PhD, Margherita Ruoppolo, PhD, Thea Kalebic, Fabrizio Pane, MD
Journal: Blood
Blood (2008) 112 (11): 3186.
https://doi.org/10.1182/blood.V112.11.3186.3186
Published: 2008
Journal Articles

Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL –negative chronic myeloproliferative disorders

Clinical Trials & Observations Brief Report
Marianna David, Nicholas C. P. Cross, Sonja Burgstaller, Andrew Chase, Claire Curtis, Raymond Dang, Martine Gardembas, John M. Goldman, Francis Grand, George Hughes, Francoise Huguet, Louise Lavender, Grant A. McArthur, Francois X. Mahon, Giorgio Massimini, Junia Melo, Philippe Rousselot, Robin J. Russell-Jones, John F. Seymour, Graeme Smith, Alastair Stark, Katherine Waghorn, Zariana Nikolova, Jane F. Apperley
Journal: Blood
Blood (2006) 109 (1): 61–64.
https://doi.org/10.1182/blood-2006-05-024828
Published: 2006
Journal Articles

Monitoring CML after nonmyeloablative transplantations: how negative is negative?

Jaspal Kaeda, Jane Apperley, Junia Melo, Nicolas Cross, John Goldman
Journal: Blood
Blood (2003) 101 (12): 5084–5085.
https://doi.org/10.1182/blood-2003-01-0086
Published: 2003